← Back to headlines
UniQure N.V. Upgraded to Overweight as Huntington’s Disease Program Advances
UniQure N.V. (QURE) has seen its stock upgraded to 'Overweight' by analysts, attributed to the advancement of its Huntington’s Disease program.
25 Jun, 12:41 — 25 Jun, 12:41
Sources
Showing 1 of 1 sources
